Invention Grant
- Patent Title: Sulfide alkyl compounds for HBV treatment
-
Application No.: US16235167Application Date: 2018-12-28
-
Publication No.: US10710959B2Publication Date: 2020-07-14
- Inventor: Austin Chen , Yalda Bravo , Nicholas Stock , Bijan Pedram , Jason Jacintho , Ryan C. Clark
- Applicant: NOVIRA THERAPEUTICS, INC.
- Applicant Address: US PA Doylestown
- Assignee: NOVIRA THERAPEUTICS, INC.
- Current Assignee: NOVIRA THERAPEUTICS, INC.
- Current Assignee Address: US PA Doylestown
- Agency: Lathrop GPM LLP
- Agent Brian C. Trinque
- Main IPC: C07C323/53
- IPC: C07C323/53 ; C07C323/22 ; C07C323/23 ; C07C323/62 ; C07D213/81 ; C07D213/82 ; C07D295/084 ; C07D295/155 ; C07D295/192 ; C07D307/10 ; C07D307/16 ; C07D309/04 ; C07D309/08 ; C07D487/10 ; A61K31/5375 ; A61K31/196 ; A61K31/351 ; A61K31/341 ; A61K31/24 ; C07D305/06 ; A61K31/337 ; A61K31/18 ; A61K31/4453 ; A61K31/495 ; A61K31/397 ; A61K45/06 ; A61K31/167 ; A61K31/192 ; A61K31/216 ; A61K31/44 ; A61K31/4412 ; C07C323/25 ; C07C323/52 ; C07D307/18
Abstract:
The present invention includes a method of inhibiting, suppressing or preventing HBV infection in an individual in need thereof, comprising administering to the individual a therapeutically effective amount of at least one compound of the invention.
Public/Granted literature
- US20190202780A1 SULFIDE ALKYL COMPOUNDS FOR HBV TREATMENT Public/Granted day:2019-07-04
Information query
